Healthcare & Life Sciences
Oblenio Bio
United Statesobleniobio.com
Oblenio Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series B.
Activeseries-b
series-b
Stage
About Oblenio Bio
Based in the United States, Oblenio Bio is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences.
Oblenio Bio develops LBL-051, a tri-specific T-cell engager antibody therapy targeting BCMA, CD19, and CD3 to deplete pathological B-cells and plasma cells, aiming to treat refractory autoimmune diseases and achieve long-term drug-free remission.
Explore Oblenio Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.